Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-035099
Filing Date
2021-09-03
Accepted
2021-09-03 16:00:21
Documents
2
Period of Report
2021-08-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2864
2 EX-24 DOCUMENT attachment1.htm EX-24 4049
  Complete submission text file 0000899243-21-035099.txt   8357
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540
Business Address
Parks Diane L. (Reporting) CIK: 0001781026 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-28386 | Film No.: 211236396